Phillip Frost bought into COCP - Insider buy 🚨

Noticed an interesting insider purchase that crossed the tape. According to the latest insider filings: Ticker: COCP Company: Crystal Pharma, Inc. Insider: Phillip Frost (MD et al) Role: Director / 10% owner Trade type: P – Purchase Trade date: 12/31/2025 Filing date: 01/02/2026 Price: $0.95 per share Shares bought: 50,000 Total value: ~$47,275 Resulting ownership: ~1,865,651 shares Change in ownership: +3% Not a massive buy in dollar terms, but still notable given Frost’s history and the fact this was an open-market purchase, not options or compensation. Buying sub-$1 biotech shares with personal cash is usually at least worth keeping an eye on. Could be nothing, could be confidence ahead of upcoming developments — but insiders buying at these levels always makes me add it to the watchlist. As always, not financial advice. Do your own DD.